Buyer & investor transaction history
GlaxoSmithKline (GSK-Pfizer consumer joint venture) acquisitions
Explore 1 reviewed acquisitions involving GlaxoSmithKline (GSK-Pfizer consumer joint venture) as the buyer or investor. Compare transaction dates, targets, values and available valuation multiples, then open any comp for its sources and calculation basis.
Coverage includes published FundComb transactions recorded under GlaxoSmithKline (GSK-Pfizer consumer joint venture). Subsidiaries, other names and undisclosed activity may be recorded separately.
- Reviewed transactions
- 1
- With value data
- 0
- With revenue multiples
- 0
- Transaction years
- 2018
Sortable transaction comps
GlaxoSmithKline (GSK-Pfizer consumer joint venture) transaction table
Rows with reported value
0 / 1
Acquisition EV, USD
-
Investment EV, USD
-
Median EV / revenue
-
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
1 shown of 1 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer Consumer Healthcare Control (68%) | 2018-12-19 | GlaxoSmithKline (GSK-Pfizer consumer joint venture) | Undisclosed | Undisclosed | - | - | United States & Global | Estimated 1 source |
Explore related tags
Continue to the full transaction history for each tag.
Source coverage varies by transaction. Announced deals, minority investments and capital raises retain their own labels; an investment amount is separate from enterprise value. Read the methodology.